SLP | tickerfilter.com

Fundamental analysis

59%

Profitability 47%

Dept financing 2%

Liquidity 75%

Performance 80%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

4.26%

1 Month

-10.55%

3 Months

-11.98%

6 Months

-17.75%

1 Year

-49.76%

2 Year

-42.74%

Key data

Stock price

$24.83

P/E Ratio

80.20

DAY RANGE

$23.74 - $25.78

EPS

$0.40

52 WEEK RANGE

$23.01 - $51.22

52 WEEK CHANGE

-$51.05

MARKET CAP

582.279 M

YIELD

0.83%

SHARES OUTSTANDING

20.111 M

DIVIDEND

$0.06

EX-DIVIDEND DATE

07-29-2024

NEXT EARNINGS DATE

07-01-2025

BETA

1.05

PUBLIC FLOAT

AVERAGE 10 VOLUME

$341,625

AVERAGE 30 VOLUME

$243,641

Company detail

CEO: Shawn M. O'Connor
Region: US
Website: simulations-plus.com
Employees: 160
IPO year: 1997

Issue type: Common Stock
Market: XNAS
Industry: Computer Software/Computer Integrated Systems Design
Sector: Manufacturing

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym; IPFsym; RENAsym; MITOsym.

SLP - Simulations Plus, Inc.